House Democrats Propose Drug Import Reforms

Law360, New York (April 18, 2008, 12:00 AM EDT) -- U.S. House of Representatives Democrats are pushing proposals intended to boost the U.S. Food and Drug Administration's ability to monitor drug and medical device imports and ensure that U.S. consumers know where their medications are manufactured.

The draft legislation pushed by leaders of the House Energy and Commerce Committee Thursday includes provisions that would require country-of-origin labeling on prescription drugs. Medical devices would also have to indicate their country of manufacture.

It also would require all companies exporting drug or medical device products to the United...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.